Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer
Conditions: Breast Cancer; Menopause; OsteopeniaInterventions: Drug: Risedronate; Drug: PlaceboSponsor: Hospices Civils de LyonCompleted - verified October 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Actonel | Breast Cancer | Cancer | Cancer & Oncology | Men | Menopause | Research | Risedronate | Study | Women